Mangoceuticals (MGRX) Free Cash Flow (2023 - 2026)

Mangoceuticals has disclosed Free Cash Flow across 4 years of filings, most recently posting -$1.3 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$1.3 million, up 42.35% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.9 million (up 20.51% YoY), and the FY2025 annual result was -$5.9 million, down 20.28% from the prior year.
• Free Cash Flow came in at -$1.3 million for Q1 2026 at Mangoceuticals, down from -$1.1 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$991131.0 in Q1 2024 to a low of -$2.3 million in Q1 2025.
• The 4-year median for Free Cash Flow is -$1.3 million (2026), against an average of -$1.5 million.
• Across the five-year window, Free Cash Flow surged 45.3% in 2024 and sank 129.51% in 2025, its largest moves.
• Mangoceuticals' Free Cash Flow stood at -$1.7 million in 2023, then surged by 33.47% to -$1.1 million in 2024, then increased by 4.59% to -$1.1 million in 2025, then retreated by 21.67% to -$1.3 million in 2026.
• The last three Free Cash Flow figures came in at -$1.3 million (Q1 2026), -$1.1 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.